1. Minimally invasive direct coronary artery bypass improves late survival compared with drug-eluting stents in isolated proximal left anterior descending artery disease: A 10- year follow-up, single-center, propensity score analysis 
Umberto Benedetto, MD, PhD, Shahzad G. Raja, MRCS, FRCS(C-Th), Rafik F.B. Soliman, MD, FRCS(C-Th), Alberto Albanese, MD, Anand Jothidasan, MRCS, Charles D. Ilsley, MD, Mohamed Amrani, MD, PhD, FECTS 
The Journal of Thoracic and Cardiovascular Surgery 
Volume 148, Issue 4, Pages (October 2014)
DOI: /j.jtcvs
Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

2. Figure 1
Survival curves according to Left, treatment and Right, type of drug-eluting stent implanted. HR, Hazard ratio; DES-PCI, percutaneous coronary intervention with drug-eluting stent; MIDCAB, minimally invasive direct coronary artery bypass; ES, eluting stent; RR, repeat revascularization.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )
Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

3. Figure 2
Probability for late death for minimally invasive direct coronary artery bypass (MIDCAB) versus percutaneous coronary intervention with drug-eluting stents (DES-PCI) stratified by age, diabetes status, and creatinine (crea) > 200 mmol/L.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )
Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions